AVRO - Avrobio Inc. - Stock Price & Catalysts • BiopharmIQ

Enterprise Value

-54.62M

Cash

124.7M

Avg Qtr Burn

-18.76M

Short % of Float

7.75%

Insider Ownership

3.31%

Institutional Own.

66.00%

Qtr Updated

06/30/23

Drug Pipeline

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
AVR-RD-05 Details Mucopolysaccharidoses, Mucopolysaccharidosis type II, Rare diseases, Rare genetic disease, Genetic disorder	Failed Discontinued	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
AVR-RD-04 Details Cystinosis	Failed Discontinued	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
AVR-RD-02 Details Gaucher disease	Failed Discontinued	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
AVR-RD-01 Details Genetic disorder, Fabry disease	Failed Discontinued	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.